Ethyl 2-(4-bromo-2-fluorophenyl)-7-(5-fluoro-3-pyridinyl)pyrazolo[1,5-a]pyrimidine-5-carboxylate
C20H13BrF2N4O2 — CID 142600094
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 2-(4-bromo-2-fluorophenyl)-7-(5-fluoro-3-pyridinyl)pyrazolo[1,5-a]pyrimidine-5-carboxylate
Ethyl 2-(4-bromo-2-fluorophenyl)-7-(5-fluoro-3-pyridinyl)pyrazolo[1,5-a]pyrimidine-5-carboxylate (PubChem CID 142600094) has the molecular formula C20H13BrF2N4O2 and a molecular weight of 459.25 g/mol. Its IUPAC name is ethyl 2-(4-bromo-2-fluorophenyl)-7-(5-fluoro-3-pyridinyl)pyrazolo[1,5-a]pyrimidine-5-carboxylate.
Molecular Properties
| Compound Name | Ethyl 2-(4-bromo-2-fluorophenyl)-7-(5-fluoro-3-pyridinyl)pyrazolo[1,5-a]pyrimidine-5-carboxylate |
|---|---|
| PubChem CID | 142600094 |
| Molecular Formula | C20H13BrF2N4O2 |
| Molecular Weight | 459.25 g/mol |
| Exact Mass | 458.02 |
| IUPAC Name | ethyl 2-(4-bromo-2-fluorophenyl)-7-(5-fluoro-3-pyridinyl)pyrazolo[1,5-a]pyrimidine-5-carboxylate |
| SMILES | CCOC(=O)c1cc(-c2cncc(F)c2)n2nc(-c3ccc(Br)cc3F)cc2n1 |
| InChI | InChI=1S/C20H13BrF2N4O2/c1-2-29-20(28)17-7-18(11-5-13(22)10-24-9-11)27-19(25-17)8-16(26-27)14-4-3-12(21)6-15(14)23/h3-10H,2H2,1H3 |
| InChIKey | GUMQKYRMKTWLMK-UHFFFAOYSA-N |
| XLogP | 4.68 |
| TPSA | 69.38 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.25 |
| LogP ≤ 5 | 4.68 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142600094 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.